Glen Burkhardt - Nov 19, 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
VP, Human Resources
Signature
/s/ John P. Sharp, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
Nov 19, 2021
Transactions value $
-$2,076
Form type
4
Date filed
11/23/2021, 05:50 PM
Previous filing
May 24, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $11.6K +5.77K $2.01* 5.77K Nov 19, 2021 Direct F1
transaction PHASQ Common Stock Sale -$13.7K -5.77K -100% $2.37* 0 Nov 19, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.